Strados Labs’ RESP™ Biosensor is currently being used in a clinical trial at Lurie Children’s to determine if the technology can accurately detect wheezing and other symptoms of asthma exacerbation in children. PHILADELPHIA, PA – September 26th, 2023 – Strados...
PHILADELPHIA, PA – August 31, 2023 – Strados Labs is thrilled to announce its selection as a quarterfinalist for the prestigious 2023 Digital Health Awards, presented by the Digital Health Hub Foundation. Strados Labs was chosen as a quarterfinalist for the Best in...
Clario has partnered with Strados Labs to offer its customers the RESP™ Biosensor System, an advanced technological innovation for the at-home capture of lung sounds. The revolutionary device enables Clario to support the capture of additional clinical respiratory...
Nick Delmonico, Cofounder and CEO of Strados Labs presented live at ATA 2023 on March 6th in San Antonio, TX and was named a winner in the 'Tools that Deliver Care' category. Philadelphia, PA March 8, 2023 – Strados Labs today announced that it was named a winner in...
PENSACOLA, FLORIDA, UNITED STATES, February 2, 2023 — Strados Labs announced today that their remote monitoring solution, the Strados™ Care Respiratory Platform, which includes the RESP™ Biosensor, can now be found on the Defense Logistics Agency’s Electronic...
Starting in early 2023 the biopharmaceutical company will use the Strados RESP™ Biosensor to remotely monitor cough and crackles in patients at home. Philadelphia, PA January 26, 2023 – Strados Labs today announced a collaboration with Boehringer Ingelheim to remotely...
